In: Accounting
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:
1 |
Dec. 31, 20Y3 |
Dec. 31, 20Y2 |
|
2 |
Assets |
||
3 |
Cash |
$625,650.00 |
$586,340.00 |
4 |
Accounts receivable (net) |
228,170.00 |
208,030.00 |
5 |
Inventories |
641,480.00 |
617,130.00 |
6 |
Investments |
0.00 |
240,290.00 |
7 |
Land |
328,170.00 |
0.00 |
8 |
Equipment |
706,070.00 |
552,300.00 |
9 |
Accumulated depreciation-equipment |
(165,580.00) |
(147,010.00) |
10 |
Total assets |
$2,363,960.00 |
$2,057,080.00 |
11 |
Liabilities and Stockholders’ Equity |
||
12 |
Accounts payable (merchandise creditors) |
$424,300.00 |
$404,860.00 |
13 |
Accrued expenses payable (operating expenses) |
41,850.00 |
52,880.00 |
14 |
Dividends payable |
23,200.00 |
19,880.00 |
15 |
Common stock, $2 par |
150,000.00 |
100,000.00 |
16 |
Paid-in capital: Excess of issue price over par—common stock |
417,500.00 |
280,000.00 |
17 |
Retained earnings |
1,307,110.00 |
1,199,460.00 |
18 |
Total liabilities and stockholders’ equity |
$2,363,960.00 |
$2,057,080.00 |
The income statement for the year ended December 31, 20Y3, is as follows:
1 |
Sales |
$5,378,129.00 |
|
2 |
Cost of goods sold |
3,306,510.00 |
|
3 |
Gross profit |
$2,071,619.00 |
|
4 |
Operating expenses: |
||
5 |
Depreciation expense |
$18,570.00 |
|
6 |
Other operating expenses |
1,755,879.00 |
|
7 |
Total operating expenses |
1,774,449.00 |
|
8 |
Operating income |
$297,170.00 |
|
9 |
Other income: |
||
10 |
Gain on sale of investments |
40,390.00 |
|
11 |
Income before income tax |
$337,560.00 |
|
12 |
Income tax expense |
133,650.00 |
|
13 |
Net income |
$203,910.00 |
Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:
a. The investments were sold for $280,680 cash. | |
b. Equipment and land were acquired for cash. | |
c. There were no disposals of equipment during the year. | |
d. The common stock was issued for cash. | |
e. There was a $96,260 debit to Retained Earnings for cash dividends declared. |
Required
Prepare a statement of cash flows, using the direct method of presenting cash flows from operating activities.
Solution
Livers Inc
Cash Flow Statement using the direct method:
Cash Flow Statement (Direct Method of presenting cash flows from operating activities) for the year ended December 31, 20Y3j |
||||
Cash flow from operating activities: |
||||
Cash receipts from customers |
$5,357,989 |
|||
Cash paid to suppliers |
($3,311,420) |
|||
Cash generated from operations |
$2,046,569 |
|||
Operating expenses paid |
($1,766,909) |
|||
Income tax expense |
($133,650) |
|||
Net cash provided by operating activities |
$146,010 |
|||
Cash flow from investing activities: |
||||
Proceeds from sale of investment |
$280,680 |
|||
Purchase of land |
($328,170) |
|||
Purchase of equipment |
($153,770) |
|||
Net cash provided by investing activities |
($201,260) |
|||
Cash flow from financing activities: |
||||
Proceeds from issue of stock |
$187,500 |
|||
Dividends paid |
($92,940) |
|||
Cash flow from financing activities |
$94,560 |
|||
Net increase in cash |
$39,310 |
|||
Beginning balance of cash |
$586,340 |
|||
Ending balance of cash |
$625,650 |
Workings –
Sales $5,378,129
Less: increase in accounts receivable $20,140
Cash receipts from customers $5,357,989
Cost of goods sold $3,306,510
Add: increase in inventory $24,350
Less: increase in accounts payable ($19,440)
Cash paid to suppliers $3,311,420
Operating expenses $1,755,879
Add: decrease in accrued expenses payable $11,030
Operating expenses paid $1,766,909
Cash Dividends declared $96,260
Add: beginning balance $19,880
Less: Ending balance ($23,200)
Cash dividends paid $92,940